GE Healthcare Discovery CT750 HD - Manual (Page 47)

Veo is the next step in GE’s commitment to lower-dose
CT. Our ASiR technology, introduced with the launch of
the Discovery CT750 HD, offers fast reconstructions and
may allow for low-dose imaging without compromise —
an ideal approach for routine, robust imaging. By push-
ing the possibilities even further, Veo represents added
capability for the most sensitive cases. By changing
the rules, these potential dose-reduction capabilities
open up exciting new possibilities in CT.
Veo establishes new rules in the relationship between
image quality and dose reduction. Veo can give the
clinicians the diagnostic information they need and
may allow for it to be done at a previously unthinkable
low dose. 1 So at an equivalent dose, Veo may deliver
dramatically better aspects of image quality.
The rules have changed. But the goal hasn’t.
Radiologists and clinicians have another powerful new
tool to deliver more informed, confident diagnoses. And
above all else, Veo can help achieve what has always
been the ultimate goal — the best patient care available.
DLP 3.16 mGy.cm, 0.05 mSv, obtained by EUR-16262 EN, using a chest factor of 0.017*DLP
1. In clinical practice, the use of Veo may reduce CT patient dose depending on the clinical task, patient size, anatomical location and
clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic
image quality for the particular clinical task.
GE Healthcare Discovery CT750 HD 47